Contact Us

Contact Us

Please contact us below with any questions

info@quadratech.co.uk

+44 (0)33 3321 2371

Side Contact
×
Sign up to our newsletter Click Here
quadratech Logo
{{ toggleHam ? 'CLOSE' : 'MENU' }}
Next Day & International Delivery
Competitive Pricing
Over 30 Years Experience
Based In The UK

Featured Products

Our Product Ranges

Recieve our latest news

Sign up to our newsletter

Our Company

 

With over 30 years of trading experience, Quadratech Diagnostics Limited has always been and remains committed to providing the highest quality state-of-the-art medical diagnostic and research products. Since the company was founded in 1990, we have expanded to encompass the following main areas: HaemostasisAntigens, Antibodies and ToxinsRapid and POC TestsParasitology and Veterinary.

Quadratech Diagnostics Limited is a corporate member of the Institute of Biomedical Scientists (IBMS) and the British Society for Haemostasis and Thrombosis (BSHT). We are a recognised supplier to the UK National Health Service (NHS), the Irish Health Service Executive (HSE), private laboratories, the UK pharmaceutical industry, and university research groups. Quadratech Diagnostics Limited became incorporated as a limited company in 1998 and is ISO 9001:2015 certified.

Our Product Brands

Latest News

Chromogenic Substrates in Haemostasis

Chromogenic substrates are small synthetic peptides which mimic the natural substrate of the enzyme and have a detector chromophore, typically para-nitroaniline (pNA), attached to the cleavage site. Enzymatic cleavage releases pNA and results in a colour change, which can be followed spectrophotometrically and is proportional to the activity of the enzyme. The concept of chromogenic […]

Haemostasis January & February 2025 News

Our round-up of the latest developments from across the haemostasis industry for January & February 2025. REGULATORY Star Therapeutics’ VGA039 (Protein S mAb) granted FDA Fast Track designation for the treatment of  Von Willebrand disease (VWD) (7 Jan) CLINICAL PharmaEssentia announced positive topline Ph3 data from SURPASS-ET study evaluating Ropeginterferon Alfa-2b-njft (P1101) for Essential Thrombocythemia […]

Haemostasis March 2025 Journal Club

Keep informed about evolving science and clinical practice with our March 2025 compilation of the latest studies, guidelines, and perspectives in haemostasis. GUIDELINES Devreese KMJ, Bertolaccini ML, Branch DW, et al. An update on laboratory detection and interpretation of antiphospholipid antibodies for diagnosis of antiphospholipid syndrome: guidance from the ISTH-SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies. J […]

Our Accreditations

Cookie Consent

Cookies help us deliver our services. By using our services, you agree to our use of cookies.